SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-16-010958
Filing Date
2016-02-16
Accepted
2016-02-16 11:37:42
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g0216brio_neurotrope.htm SC 13G 47051
  Complete submission text file 0001213900-16-010958.txt   48710
Mailing Address 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102
Business Address 50 PARK PLACE, SUITE 1401 NEWARK NJ 07102 (973) 242-0005
Neurotrope, Inc. (Subject) CIK: 0001513856 (see all company filings)

IRS No.: 463522381 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88549 | Film No.: 161424961
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BRIO CAPITAL MANAGEMENT LLC 100 MERRICK ROAD SUITE 401W ROCKVILLE CENTRE NY 11570
Business Address C/O BRIO CAPITAL MANAGEMENT LLC 100 MERRICK ROAD SUITE 401W ROCKVILLE CENTRE NY 11570 516-536-0500
Brio Capital Master Fund Ltd. (Filed by) CIK: 0001560894 (see all company filings)

IRS No.: 981072321 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G